Planning of Kidney Replacement Therapy in Advanced CKD using the KFRE formula in a Spanish Multicenter Cohort

Clicks: 1
ID: 316464
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #106 of 128 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 128 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background The Kidney Failure Risk Equation (KFRE) is widely used to estimate the risk of kidney replacement therapy (KRT), but evidence in real-world multicentre advanced CKD (ACKD) cohorts—particularly among older patients with substantial competing mortality—remains limited. Methods We conducted a multicentre retrospective cohort study including adults with ACKD (baseline eGFR <20 mL/min/1.73 m²) followed at specialised multidisciplinary clinics in Barcelona and Seville (2017–2022). The 2-year 4-variable KFRE (age, sex, eGFR, UACR) was externally validated for predicting KRT initiation, treating death as a competing event. Discrimination was assessed using time-dependent AUC; calibration was evaluated using decile-based plots and quantitative metrics (calibration-in-the-large, Brier score) using Fine–Gray competing risk methods. Clinical utility was explored using decision curve analysis (DCA) and a 20% KFRE threshold in patients aged ≥65 years. Results A total of 503 patients were included. During follow-up, 248 patients initiated KRT and 94 died before KRT. The 2-year 4-variable KFRE showed good discrimination (time-dependent AUC 0.82, 95% CI 0.73–0.91), preserved across age strata. Calibration demonstrated appropriate risk ordering across deciles with mild underestimation (CITL −0.21 by Fine–Gray; Brier score 0.23). In patients aged ≥65 years, a KFRE ≥20% was strongly associated with KRT initiation in competing risk models (SHR 5.92, 95% CI 4.08–8.60). DCA showed positive net benefit across clinically relevant thresholds. Conclusions In a multicentre Spanish ACKD cohort, the 2-year KFRE demonstrated robust discrimination and acceptable calibration. These findings highlight theclinical utility of the KFRE for risk stratification and KRT planning in older patients with advanced CKD.
Reference Key
openalex_W7163988658 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alba Temprado Collado, Néstor Toapanta, Mario Román Cabezas, Hector Bedoya, Efrain Tatis, Luis Gil Sacaluga, María Cristina Sánchez-Pozo, Navdeep Tangri, María José Soler, Francisco Javier Toro Prieto
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag192
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.